To determine the frequency of ROS1 translocation in lung cancers and clinical characteristics in Taiwan, we first retrospectively examined 100 NSCLC patients treated at Lin-Kou Chang Gung Memorial Hospital, TaoYuan, Taiwan from 2010 to 2015. This evidence concerns the gene ROS1 and lung cancer.